Infosys slides 2.5% intraday despite Japan JV buzz; stock near one-month low
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓Infosys shares fell 2.49 per cent to ₹1,081.20 on Thursday despite a new joint venture with Japan’s NTT Docomo.
- ✓The stock hit a one-month low as investors worried about global AI valuations and a stronger rupee.
- ✓Many traders sold off the shares, which have dropped 33.67 per cent this year.
Story at a Glance
- Category
- Indian Markets
- Reported By
- Business Line
- Reading Speed
- 2 Minute(s)
- Market Focus
- India Economy
Shares of Infosys fell as much as 2.49 per cent to ₹1,081.20 in intraday trade on the National Stock Exchange on Thursday, extending a sharp week-long decline even as the company's subsidiary announced a joint venture with Japanese telecom major NTT Docomo.
By 12.16 PM, the stock was trading at ₹1,081.20, down ₹27.60 from its previous close of ₹1,108.80. It touched an intraday low of ₹1,073.20, not far above its 52-week low of ₹980.40 hit on September 29.
The stock opened at ₹1,096.30 and hit a high of ₹1,097.00 before turning sharply lower. Traded volume stood at 54.51 lakh shares worth ₹589.20 crore, indicating active participation.
The stock has been a consistent underperformer. It has shed 6.10 per cent in the past week, 4.40 per cent over the past month, and is down 33.67 per cent year-to-date, significantly lagging the Nifty 50's 3.02 per cent year-to-date loss. Its 52-week high of ₹1,728.00 was recorded on February 3.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
Business Line
Read the full, original unfiltered story directly on the publisher's portal.
This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.